Evidence map›Paper›PMID 37183908›Full record

ArticleThe British journal of radiology2023

T1 mapping and multimodel diffusion-weighted imaging in the assessment of cervical cancer: a preliminary study.

Shujian Li, Jie Liu, Wenhua Zhang, Huifang Lu, Weijian Wang, Liangjie Lin, Yong Zhang, Jingliang Cheng

Abstract read
In one paragraph

Article in The British journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shujian LiDepartment of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jie LiuDepartment of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenhua ZhangDepartment of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Huifang LuDepartment of Gynecology and Obstetrics, Huaihe Hospital of Henan University, Kaifeng, China.
Weijian WangDepartment of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Liangjie LinAdvanced Technical Support, Philips Healthcare, Beijing, China.
Yong ZhangDepartment of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jingliang ChengDepartment of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the clinical feasibility of T1 mapping and multimodel diffusion-weighted imaging (DWI) for assessing the histological type, grade, and lymphovascular space invasion (LVSI) of cervical cancer.

methodsEighty patients with cervical cancer and 43 patients with a normal cervix underwent T1 mapping and DWI with 11 b-values (0-2000 s/mm

resultsNative T1 and DWI-derived parameters differed significantly between cervical cancer and normal cervix (all

conclusionBoth T1 mapping and multimodel DWI can effectively differentiate cervical cancer from a normal cervix and cervical adenocarcinoma from SCC. Furthermore, multimodel DWI may provide quantitative metrics for non-invasively predicting histological grade and LVSI status in SCC patients. ADVANCES IN KNOWLEDGE: Combined use of T1 mapping and multimodel DWI may provide more comprehensive information for non-invasive pre-operative evaluation of cervical cancer.

Indexed as

AdenocarcinomaCarcinoma, Squamous CellUterine Cervical NeoplasmsDiffusion Magnetic Resonance ImagingFemaleHumans

Identifiers

PMID37183908
PMCPMC10392640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.